ArticleCancer cell international2026

Targeting ABCA3 impedes tumor progression and EGFR-TKI resistance in EGFR-mutant LUAD.

Zhexian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.